Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

BACKGROUND: As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate goal of e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Infect Dis
Autors principals: Adland, Emily, Jesuthasan, Gerald, Downs, Louise, Wharton, Victoria, Wilde, Gemma, McNaughton, Anna L., Collier, Jane, Barnes, Eleanor, Klenerman, Paul, Andersson, Monique, Jeffery, Katie, Matthews, Philippa C.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6137907/
https://ncbi.nlm.nih.gov/pubmed/30217169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-3367-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars